Curis Revenue Quarterly YoY Growth:
-91.59% for Dec. 31, 2012Curis Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -91.59% |
| Dec. 31, 2012 | -88.03% |
| Sept. 30, 2012 | 292.7% |
| June 30, 2012 | 1008% |
| March 31, 2012 | 7655% |
| Dec. 31, 2011 | 13949% |
| Sept. 30, 2011 | -95.46% |
| June 30, 2011 | 298.3% |
| March 31, 2011 | -98.94% |
| Dec. 31, 2010 | -94.18% |
| Sept. 30, 2010 | 323.7% |
| June 30, 2010 | 55.91% |
| March 31, 2010 | 108.0% |
| Dec. 31, 2009 | -44.46% |
| Sept. 30, 2009 | 782.5% |
| June 30, 2009 | -97.96% |
| March 31, 2009 | 192.0% |
| Dec. 31, 2008 | -72.97% |
| Sept. 30, 2008 | -93.39% |
| June 30, 2008 | 152.9% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
CRIS Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Threshold Pharmaceuticals | 1060% |
| Ariad Pharmaceuticals | 7880% |
| XOMA | -24.93% |
CRIS Revenue Quarterly YoY Growth Rankings
| Overall |
39th percentile 4846 of 8002 |
| Sector |
24th percentile 488 of 650 in Healthcare |
| Industry |
43rd percentile 135 of 237 in Biotechnology |
CRIS Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -98.94% | Mar 2011 |
| Maximum | 13949% | Dec 2011 |
| Average | 1202% |
